Pharmafile Logo
Pharmafocus logo
Advanced Search
Eisai image

Eisai Alzheimer’s drug to see China review

March 4, 2015
Sales and Marketing Alzheimer's, Aricept, China, Eisai, donepezil hydrochloride

Alzheimer’s drug Aricept from Eisai has been accepted for review in China to treat patients with the most severe form …

News
Teva image

Teva to sell US manufacturing plant

March 4, 2015
Manufacturing and Production, Sales and Marketing G&W Laboratories, Pennsylvania, Teva

Teva Pharmaceutical has announced that it has signed an agreement to sell a US manufacturing facility to G&W Laboratories. The …

News

EU widens indications for Pfizer vaccine

March 4, 2015
Research and Development, Sales and Marketing EC, EMA, Pfizer, pneumococcal polysaccharide conjugate vaccine, prevenar

Pfizer has gained approval from the European Commission which has signed off on an EMA decision to recommend Prevenar 13 …

News
Christophe Weber image

New chief executive for Takeda

March 4, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actos, Millennium, Nycomed, Takeda, Yasuchika Hasegawa, christophe weber

Japanese pharma giant Takeda has added the title of chief executive to its representative director, president and chief operating officer …

News

Scottish reforms proven to work says SMC

March 4, 2015
Sales and Marketing NHS, NICE, Onglyza, PACE, SMC, Scotland, anne lee, scottish

The chief pharma advisor for the Scottish Medicines Consortium Anne Lee says changes to its processes have contributed to improved …

News
richard_douglas

Finance director general for Department of Health retiring

March 4, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Department of Health, DoH, director general, finance, richard douglas

The Department of Health’s director general for finance and the NHS Richard Douglas is to retire at the end of …

Appointment
AZ image

AstraZeneca completes respiratory deal with Actavis

March 3, 2015
Research and Development, Sales and Marketing Actavis, AstraZeneca, COPD, Daliresp, Tudorza Pressair, aclidinium bromide inhalation powder, respiratory, roflumilast

AstraZeneca has completed its acquisition of Dublin-headquartered firm Actavis with its branded respiratory portfolio deal worth $700 million. The agreement …

News
Boehringer image

Boehringer chases approval for anti-Pradaxa drug

March 3, 2015
Sales and Marketing Boehringer, Boehringer Ingelheim, Pradaxa, bleeding, dabigatran etexilate, idarucizumab

Boehringer Ingelheim is launching new drug applications for its investigational treatment to reverse the effects of its blood-thinning drug Pradaxa. …

News
Takeda image

Takeda expands in Singapore

March 3, 2015
Manufacturing and Production Singapore, Takeda, biopolis, emerging markets, vaccines

Japanese pharma giant Takeda has set up new Singapore offices in the Biopolis biomedical complex with the aim of expanding …

News
Chiesi image

Chiesi reprimanded again over Fostair drug

March 3, 2015
Manufacturing and Production, Medical Communications, Sales and Marketing ABPI, Chiesi, PMCPA, code, formoterol/beclometason, fostair

Chiesi has been reprimanded after it breached the ABPI’s Code of Practice for its promotion of asthma inhaler Fostair. The …

News
Harvoni image

NICE recommends Harvoni for hepatitis C

March 3, 2015
Sales and Marketing Gilead, NICE, harvoni, hepatitis C, ledipasvir-sofosbuvir

NICE has signalled a provisional OK for Gilead’s Harvoni to be used as a treatment for hepatitis C by the …

News
beth_ratliff

Premise Health senior joins Nashville Health Care Council

March 3, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing nashville health care council, premise health

US worksite health and patient engagement firm Premise Health has announced that its senior VP Beth Ratliff has been selected …

Appointment
Ebola image

ZMapp trials start in Liberia

March 2, 2015
Research and Development, Sales and Marketing Africa, Ebola, Mapp, Vaccine, liberia, zmapp

Clinical trials to test the safety and efficacy of the experimental Ebola vaccine ZMapp are underway in infected parts of …

News
Eisai image

Eisai launches Lenvima in US

March 2, 2015
Sales and Marketing FDA, Japan, Lenvima, US, dtc, thyroid

Japanese firm Eisai has launched its new thyroid cancer offering Lenvima in the US, making it the first country in …

News
Novartis image

Three drugs put forward for EMA authorisation

March 2, 2015
Research and Development, Sales and Marketing Amgen, EMA, FDA, Novartis, Otsuka, jinarc, ristempa, zykadia

Novartis’ lung cancer drug Zykadia has been recommended for EU approval in patients previously treated with Pfizer’s Xalkori – the …

News
kate_black_23andme

23andMe appoints privacy officer

March 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andME, kate black

US genetics testing firm 23andMe has appointed Kate Black as its privacy officer and corporate counsel.

Appointment
Cancer image

Precision medicine: the future of cancer treatment?

March 2, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Cancer, Celgene, Precision, melanoma, oncology, underwood

There are plenty of advances in oncology treatments to be excited about – from immunotherapy to cancer vaccines and monoclonal …

Feature
GSK image

GSK and Novartis swap assets

March 1, 2015
Research and Development, Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, akt, merger, oncology, vaccines

GlaxoSmithKline’s planned major assets swap with Novartis has completed today as was predicted last week. Both firms announced the overhaul …

News
Baye image

New EU indication for Bayer and Regeneron eye drug

February 27, 2015
Sales and Marketing Bayer, European Commission, Eylea, aflibercept

Bayer and Regeneron’s Eylea is now indicated for every type of the eye disease retinal vein occlusion (RVO) thanks to …

News
Christopher Viehbacher image

Ousted Sanofi boss finds role at PureTech

February 27, 2015
Sales and Marketing Bayer, Sanofi, Viehbacher, baumann, brandicourt, pott, puretech

US science and technology R&D company PureTech has appointed the former Sanofi chief executive Christopher Viehbacher to its board. Viehbacher …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026